TICOVAC
STN: 125740
Proper Name: Tick-Borne Encephalitis Vaccine
Tradename: TICOVAC
Manufacturer: Pfizer Ireland Pharmaceuticals
Indication:
- For active immunization to prevent tick-borne encephalitis (TBE) in individuals 1 year of age and older.
Product Information
Supporting Documents
- August 13, 2021 Approval Letter - TICOVAC
- August 13, 2021 Summary Basis for Regulatory Action - TICOVAC
- August 13, 2021 Clinical Review Memo - TICOVAC
- Statistical Review - TICOVAC
- Approval History, Letters, Reviews, and Related Documents - TICOVAC